Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.
about
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.Gastrointestinal stromal tumor.Imatinib-induced pleural effusion: A case report.Practical management of patients with chronic myeloid leukemia.Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg dailyCardiotoxicity of molecularly targeted agentsCardiovascular Toxicity of Molecular Targeted Therapy in Cancer Patients: A Double-Edged SwordCardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management.Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.Chronic GvHD-associated serositis and pericarditis.Tyrosine kinase inhibitor induced isolated pericardial effusion.Pleural effusion: a rare side effect of nilotinib-a case report.A Suspected Case of an Alveolar Haemorrhage Caused by Dasatinib.Dasatinib Induced Cardiac Tamponade-A Rare Association.Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study.Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromas.Comprehensive review of cardiovascular toxicity of drugs and related agents.ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.The intracellular juxtamembrane domain of discoidin domain receptor 2 (DDR2) is essential for receptor activation and DDR2-mediated cancer progression.
P2860
Q27027354-82AC77B9-D041-46DA-8ED7-F0C2F6EFD2D8Q33489084-4572FCF4-08A4-447C-9AA2-D5243E5FAB7DQ33573367-3C94E352-B9DB-4A67-8E43-7AC5B1F24094Q33849146-40EFF308-79E4-43BC-A670-01A91F7DC568Q34451624-3D4FBD00-2CC0-4984-9EF4-4A90BEC39534Q35878459-DFCE7606-8284-4863-BB0F-336C1E470933Q36721511-CEF439B7-CA67-4A69-840E-5EA51E9E19A8Q36891574-123DF0E9-CC49-44C8-A86E-C2CA79C59084Q37781050-A845A271-3ADC-48C0-9D65-6E6F5F8F17A4Q37791429-952F558B-A809-48F8-B37D-6F86E5038C1DQ39279796-B917EA78-AEF2-466B-8808-64F65E6CEB07Q40229471-A01598B0-3DB1-49A9-B139-79903FCFE540Q40952850-E60A2248-D958-4296-B640-277FEFFB0CCEQ41351543-6DF73CFA-A488-4188-B4B8-7316B5AC7C94Q41809416-AFD02191-28A0-4C05-BBD0-28EB736BDC62Q41917537-4BA2D921-E8C6-471D-B910-8CBE821D6BF5Q42293055-F60BEAD9-6D1E-4DC6-BD13-6A7AB7B14D7AQ42796997-E2096D84-80E6-433D-94FA-C30C2BF7D832Q44129015-5C97B71A-F9F6-41D5-A3BE-BC504439E516Q45012004-9F765417-3670-4BA3-8D54-840D648EF561Q47556269-2C414083-0058-4FFE-9780-EFD5EF7BF2F2Q51698195-E17122FC-4155-4B68-AA7E-541490374D57Q51741088-ED801954-87AF-48E6-B768-CF6CF40D3848
P2860
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serosal inflammation (pleural ...... to tyrosine kinase inhibitors.
@en
Serosal inflammation
@nl
type
label
Serosal inflammation (pleural ...... to tyrosine kinase inhibitors.
@en
Serosal inflammation
@nl
prefLabel
Serosal inflammation (pleural ...... to tyrosine kinase inhibitors.
@en
Serosal inflammation
@nl
P2093
P1433
P1476
Serosal inflammation (pleural ...... to tyrosine kinase inhibitors.
@en
P2093
Devalingam Mahalingam
Francis J Giles
Kevin Kelly
Ronan Swords
Swaminathan Padmanabhan
P2888
P304
P356
10.1007/S11523-009-0110-4
P577
2009-04-21T00:00:00Z